Abstract:The B cell–specific enzyme activation-induced cytidine deaminase (AID) has been shown to be essential for isotype switching and affinity maturation of antibody genes during the immune response. Conversely, AID activity has also been linked to autoimmunity and tumorigenesis. Determining how AID expression is regulated in vivo is therefore central to understanding its role in health and disease. Here we use phylogenetic footprinting and high-resolution histone acetylation mapping to accurately demarcate AID gene… Show more
“…This is most likely due to the impairment in CSR caused by UNG deficiency (see later), leading to persistence of IgM + cells in the germinal center reaction to accumulate SHM, which can be selected before isotype switching has occurred. We could confirm that the spleen of Ung 2/2 mice contained more IgM + AID + cells after immunization than the controls by using an AID-GFP reporter mouse that allows identifying AID + germinal center cells in response to immunization (23). Indeed, the ratio of IgM + to IgM 2 cells in the AID + B cell population was inverted in Ung 2/2 mice compared with controls (Fig.…”
Section: Improved Affinity Maturation Of Igm In Ung-deficient Micesupporting
confidence: 54%
“…RNA was extracted using RNeasymicro kit (Qiagen) and cDNA produced using Protoscript kit (Biolabs). The suitability of AID-GFP expression in these mice to identify germinal center B cells has been established (23). PCRs were performed on cDNA using oligonucleotides OJ794 59-TCTTCTTGGCAGCAACAG-39, priming at the leader region of VH186.2 and OJ795 59-CCAGATTCTTATCAGACAGGG-39 priming at the IgH Cm1 for 35 cycles of 95˚C 20 s + 55˚C 10 s + 70˚C 9 s using KOD DNA polymerase.…”
Activation-induced deaminase converts deoxycytidine to deoxyuridine at the Ig loci. Complementary pathways, initiated by the uracil-DNA glycosylase (UNG) or the mismatch repair factor MSH2/MSH6, must process the deoxyuridine to initiate class-switch recombination (CSR) and somatic hypermutation. UNG deficiency most severely reduces CSR efficiency and only modestly affects the somatic hypermutation spectrum in vitro. This would predict isotype-switching deficiency but normal affinity maturation in Ung−/− mice in vivo, but this has not been tested. Moreover, puzzling differences in the amount of circulating Ig between UNG-deficient humans and mice make it unclear to what extent MSH2/MSH6 can complement for UNG in vivo. We find that Ab affinity maturation is indeed unaffected in Ung−/− mice, even allowing IgM responses with higher than normal affinity. Ung−/− mice display normal to only moderately reduced basal levels of most circulating Ig subclasses and gut-associated IgA, which are elicited in response to chronically available environmental Ag. In contrast, their ability to produce switched Ig in response to immunization or vesicular stomatitis virus infection is strongly impaired. Our results uncover a specific need for UNG in CSR for timely and efficient acute Ab responses in vivo. Furthermore, Ung−/− mice provide a novel model for separating isotype switching and affinity maturation during acute (but not chronic) Ab responses, which could be useful for dissecting their relative contribution to some infections. Interestingly, Ung−/− mice present with circulating autoantibodies, suggesting that UNG may impinge on tolerance.
“…This is most likely due to the impairment in CSR caused by UNG deficiency (see later), leading to persistence of IgM + cells in the germinal center reaction to accumulate SHM, which can be selected before isotype switching has occurred. We could confirm that the spleen of Ung 2/2 mice contained more IgM + AID + cells after immunization than the controls by using an AID-GFP reporter mouse that allows identifying AID + germinal center cells in response to immunization (23). Indeed, the ratio of IgM + to IgM 2 cells in the AID + B cell population was inverted in Ung 2/2 mice compared with controls (Fig.…”
Section: Improved Affinity Maturation Of Igm In Ung-deficient Micesupporting
confidence: 54%
“…RNA was extracted using RNeasymicro kit (Qiagen) and cDNA produced using Protoscript kit (Biolabs). The suitability of AID-GFP expression in these mice to identify germinal center B cells has been established (23). PCRs were performed on cDNA using oligonucleotides OJ794 59-TCTTCTTGGCAGCAACAG-39, priming at the leader region of VH186.2 and OJ795 59-CCAGATTCTTATCAGACAGGG-39 priming at the IgH Cm1 for 35 cycles of 95˚C 20 s + 55˚C 10 s + 70˚C 9 s using KOD DNA polymerase.…”
Activation-induced deaminase converts deoxycytidine to deoxyuridine at the Ig loci. Complementary pathways, initiated by the uracil-DNA glycosylase (UNG) or the mismatch repair factor MSH2/MSH6, must process the deoxyuridine to initiate class-switch recombination (CSR) and somatic hypermutation. UNG deficiency most severely reduces CSR efficiency and only modestly affects the somatic hypermutation spectrum in vitro. This would predict isotype-switching deficiency but normal affinity maturation in Ung−/− mice in vivo, but this has not been tested. Moreover, puzzling differences in the amount of circulating Ig between UNG-deficient humans and mice make it unclear to what extent MSH2/MSH6 can complement for UNG in vivo. We find that Ab affinity maturation is indeed unaffected in Ung−/− mice, even allowing IgM responses with higher than normal affinity. Ung−/− mice display normal to only moderately reduced basal levels of most circulating Ig subclasses and gut-associated IgA, which are elicited in response to chronically available environmental Ag. In contrast, their ability to produce switched Ig in response to immunization or vesicular stomatitis virus infection is strongly impaired. Our results uncover a specific need for UNG in CSR for timely and efficient acute Ab responses in vivo. Furthermore, Ung−/− mice provide a novel model for separating isotype switching and affinity maturation during acute (but not chronic) Ab responses, which could be useful for dissecting their relative contribution to some infections. Interestingly, Ung−/− mice present with circulating autoantibodies, suggesting that UNG may impinge on tolerance.
“…This is highlighted by the cancer predisposition phenotype observed in transgenic mice overexpressing AID 7 , by the finding that ectopic SHM can occur in proto-oncogenes and tumor suppressor genes [8][9][10] and by the involvement of AID in oncogenic chromosomal translocations 11,12 . AID is normally induced in germinal center B cells 13 but in order to ensure that the genetic modifications it can cause are largely restricted to the Ig loci, there are multiple points of posttranscriptional regulation such as regulation of mRNA stability and translation [14][15][16] , subcellular localization 17,18 , protein stability 19 and modification by phosphorylation [20][21][22] .…”
The enzyme Activation Induced Deaminase (AID) triggers antibody diversification in B-cells by catalyzing deamination and consequently mutation of immunoglobulin genes. To minimize off-target deamination, AID is restrained by several regulatory mechanisms including nuclear exclusion, thought to be mediated exclusively by active nuclear export. Here we identify two other mechanisms involved in controlling AID subcellular localization. AID is unable to passively diffuse into the nucleus, despite its small size, its nuclear entry requiring active import mediated by a conformational nuclear localization sequence (NLS). We also identify a determinant for AID cytoplasmic retention in its Cterminus, which hampers diffusion to the nucleus, competes with nuclear import and is critical for maintaining the predominantly cytoplasmic localization of AID in steady-state conditions. Blocking nuclear import alters the balance between these processes in favor of cytoplasmic retention, resulting in reduced isotype class switching.3
“…We postulated that if AID were to play a role in lymphomagenesis, the frequency of mature B-cell lymphomas in AID À/À Em c-myc Tg mice would be significantly reduced because AID is only expressed in mature activated B cells (Muramatsu et al, 1999;Crouch et al, 2007). Therefore, we used flow cytometry to categorize the developmental status of lymphomas, as previously described (Egle et al, 2004).…”
Section: C-myc-induced Tumor Incidence Is Not Affected By Aid Deficiencymentioning
DNA breaks caused by recombination-activating gene 1 (RAG1) and activation-induced cytidine deaminase (AID) induce c-myc/immunoglobulin (Ig) heavy chain chromosomal translocations and thereby stimulate lymphomagenesis. However, constitutive expression of c-myc alone is not sufficient to induce lymphomas. Because RAG1 and AID activity occurs outside of Ig genes, we assessed whether these enzymes provide the secondary genetic lesions in El c-myc transgenic mice to promote lymphoma development. We found that the tumor incidence and tumor phenotype in El c-myc transgenic mice is similar in AID þ / þ , AID þ /À and AID À/À backgrounds in both specific pathogen-free and conventional animal facilities, indicating that AID does not contribute to lymphoma development in El c-myc transgenic mice. To examine the role of RAG proteins in El c-myc mice, we examined El c-myc transgenic mice that harbor the Ig-HEL heavy-and light-chain transgenes, and thus have reduced RAG expression in B cells. We found that tumor incidence was not affected by these Ig transgenes. However, we found that RAG1 À/À El c-myc mice exhibited accelerated tumor development compared to controls. This data combined with our finding that El c-myc mice lived longer in the conventional facility than in the specific pathogen-free facility suggest an immunemediated activity that suppresses lymphoma development.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.